Variations in lipid levels according to menstrual cycle phase: clinical implications
- PMID: 21743815
- PMCID: PMC3130301
- DOI: 10.2217/clp.11.9
Variations in lipid levels according to menstrual cycle phase: clinical implications
Abstract
Understanding variations in lipoprotein cholesterol levels throughout the menstrual cycle is important because there may be clinical implications regarding the appropriate timing of measurement and implications on the design and interpretation of studies in women of reproductive age. Our objective was to review the evidence comparing lipoprotein cholesterol levels throughout the menstrual cycle among premenopausal women. Overall, lipoprotein cholesterol levels were observed to vary in response to changing estrogen levels. Taken together, the evidence suggests that total cholesterol and LDL-C tend to be highest during the follicular phase and to decline during the luteal phase, with HDL C highest around ovulation. Based on these findings, the menstrual cycle phase should be taken into account when evaluating lipoprotein cholesterol levels among reproductive-aged women. Measuring cholesterol levels during menses is recommended for consistent comparisons as this phase can be more reliably identified than other phases, although women within National Cholesterol Education Program acceptable ranges, but near the boundaries when tested during menses, should undergo additional tests.
Figures


Similar articles
-
Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle.J Clin Endocrinol Metab. 2004 Feb;89(2):776-82. doi: 10.1210/jc.2003-030506. J Clin Endocrinol Metab. 2004. PMID: 14764796
-
alpha-Tocopherol concentrations in plasma but not in lipoproteins fluctuate during the menstrual cycle in healthy premenopausal women.J Nutr. 1998 Jul;128(7):1150-5. doi: 10.1093/jn/128.7.1150. J Nutr. 1998. PMID: 9649599
-
Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet.J Clin Endocrinol Metab. 1996 Oct;81(10):3599-603. doi: 10.1210/jcem.81.10.8855808. J Clin Endocrinol Metab. 1996. PMID: 8855808
-
Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women.Epidemiol Rev. 2014;36(1):71-82. doi: 10.1093/epirev/mxt007. Epub 2013 Sep 15. Epidemiol Rev. 2014. PMID: 24042431 Free PMC article. Review.
-
The effect of the menstrual cycle on exercise metabolism: implications for exercise performance in eumenorrhoeic women.Sports Med. 2010 Mar 1;40(3):207-27. doi: 10.2165/11317090-000000000-00000. Sports Med. 2010. PMID: 20199120 Review.
Cited by
-
Molecular Fingerprints of Iron Parameters among a Population-Based Sample.Nutrients. 2018 Nov 19;10(11):1800. doi: 10.3390/nu10111800. Nutrients. 2018. PMID: 30463274 Free PMC article.
-
Unique features of dyslipidemia in women across a lifetime and a tailored approach to management.Am J Prev Cardiol. 2024 Apr 5;18:100666. doi: 10.1016/j.ajpc.2024.100666. eCollection 2024 Jun. Am J Prev Cardiol. 2024. PMID: 38634109 Free PMC article. Review.
-
Evaluation and management of blood lipids through a woman's life cycle.Am J Prev Cardiol. 2022 Mar 13;10:100333. doi: 10.1016/j.ajpc.2022.100333. eCollection 2022 Jun. Am J Prev Cardiol. 2022. PMID: 35345879 Free PMC article. Review.
-
Evaluating Changes in Omega-3 Fatty Acid Intake after Receiving Personal FADS1 Genetic Information: A Randomized Nutrigenetic Intervention.Nutrients. 2017 Mar 6;9(3):240. doi: 10.3390/nu9030240. Nutrients. 2017. PMID: 28272299 Free PMC article. Clinical Trial.
-
Deficiency and absence of endogenous isoprene in adults, disqualified its putative origin.Heliyon. 2021 Jan 12;7(1):e05922. doi: 10.1016/j.heliyon.2021.e05922. eCollection 2021 Jan. Heliyon. 2021. PMID: 33490682 Free PMC article.
References
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. Outlines clinical recommendations for treatment of high cholesterol for both men and women. - PubMed
-
- Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480–486. - PubMed
-
- Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 1990;10(6):1051–1057. - PubMed
-
- Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117(12):1016–1037. - PubMed
-
- Rijpkema AH, van der Sanden AA, Ruijs AH. Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas. 1990;12(3):259–285. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources